PNC Financial Services Group’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
VCM
NTCM
PNC Financial Services Group's IRMD Position: Q1 2026 in Review
PNC Financial Services Group increased its iRadimed (IRMD) stake by 1.9% in Q1 2026, buying an estimated $500 and bringing the position to 263 shares worth $25.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3584.
PNC Financial Services Group first reported a position in IRMD in Q4 2015 and has held it in 18 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.
- PNC Financial Services Group held 263 shares of iRadimed worth $25.3K as of Q1 2026.
- PNC Financial Services Group bought 5 iRadimed shares in Q1 2026, an estimated $500.
- iRadimed made up ﹤0.01% of PNC Financial Services Group's portfolio in Q1 2026, its #3584 holding.
- PNC Financial Services Group first reported a position in iRadimed in Q4 2015 and has held it in 18 quarters since.
- 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.
Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.